2012
DOI: 10.1016/j.medcli.2011.05.031
|View full text |Cite
|
Sign up to set email alerts
|

Factores que influyen en la liberación de células endoteliales progenitoras y citocinas angiogénicas tras un infarto de miocardio extenso

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0
2

Year Published

2012
2012
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 30 publications
0
1
0
2
Order By: Relevance
“…[2] Even more, the circulating EPC levels are influenced by several factors: circadian rhythms, [3] different concentrations of cytokines or growth factors in blood or pathophysiological status of the patients. [4,5] In patients with acute coronary syndrome, compared with patients with stable angina following elective coronary angioplasty, a more pronounced increment of EPC counts has been described. [6] However, this increment could be related with higher pro-inflammatory cytokine levels or with an increase in circulating endothelial cells, suggesting an inflammatory response or vascular damage, respectively.…”
mentioning
confidence: 99%
“…[2] Even more, the circulating EPC levels are influenced by several factors: circadian rhythms, [3] different concentrations of cytokines or growth factors in blood or pathophysiological status of the patients. [4,5] In patients with acute coronary syndrome, compared with patients with stable angina following elective coronary angioplasty, a more pronounced increment of EPC counts has been described. [6] However, this increment could be related with higher pro-inflammatory cytokine levels or with an increase in circulating endothelial cells, suggesting an inflammatory response or vascular damage, respectively.…”
mentioning
confidence: 99%
“…Como sucede con los niveles de VEGF 4 , los niveles má ximos de CME en sangre se alcanzan entre el quinto y el sé ptimo día postinfarto, dependiendo de la estrategia de reperfusió n 4,12 , del paciente y sus comorbilidades y del tratamiento mé dico. Domínguez et al 8 observan que los pacientes hipertensos tienen má s CME y que existe una fuerte correlació n entre ellas y los factores movilizadores, y que los diabé ticos expresan menores niveles de SDF-1 y de CME. Se sabe que los pacientes con factores de riesgo cardiovascular tienen menores niveles de factores angiogé nicos y de CME circulantes, y que el tratamiento mé dico con estatinas aumenta la respuesta de CME al dañ o miocá rdico 6 .…”
unclassified
“…La angiopoyetina y el factor de crecimiento de fibroblastos estimulan la proliferació n de CME y su diferenciació n a estructuras vasculares. En el estudio de Domínguez et al 8 no se ha relacionado con las concentraciones de CME. La TSP-1 es un factor que inhibe la angiogé nesis y su presencia se asocia a defectos funcionales de las CME.…”
unclassified